hexadecyloxypropyl
ester
acycl
nucleosid
phosphon
contain
guanin
g
hypoxanthin
hx
phosphonomethoxi
propyl
hpmp
ethyl
pee
acycl
moieti
prepar
activ
prodrug
evalu
vitro
differ
viru
famili
wherea
ester
deriv
peehx
hpmphx
antivir
inact
monoest
peeg
monoand
diester
hpmpg
show
pronounc
antivir
activ
vaccinia
viru
andor
herpesvirus
monoest
hpmpg
emerg
potent
select
deriv
dna
virus
none
compound
inhibitori
rna
virus
retrovirus
crown
acycl
nucleosid
phosphon
constitut
group
compound
wide
rang
biolog
activ
includ
antivir
cytostat
antiparasit
immunomodulatori
effect
compound
guanin
hypoxanthin
nucleobas
bear
phosphonomethoxi
propyl
hpmp
ethyl
pee
chain
report
potenti
antimalari
agent
capabl
inhibit
phosphoribosyltransferas
plasmodium
parasit
order
increas
membran
permeabl
mention
phosphon
mask
ionic
charact
drug
use
hostetl
prodrug
strategi
hexadecyloxypropyl
ester
phosphonomethoxi
propyl
guanin
hpmpg
phosphonomethoxi
propyl
hypoxanthin
hpmphx
phosphonomethoxi
ethyl
guanin
peeg
phosphonomethoxi
ethyl
hypoxanthin
peehx
prepar
activ
plasmodium
subject
anoth
studi
herein
focu
antivir
activ
variou
viru
strain
among
parent
drug
hpmpg
report
activ
compound
herp
simplex
viru
hsv
type
type
varicellazost
viru
vzv
cytomegaloviru
cmv
vaccinia
viru
ec
mm
rang
octadecyloxyethyl
ester
hpmpg
close
analog
prodrug
studi
report
display
enhanc
antivir
activ
compar
parent
drug
attach
highli
lipophil
hexadecyloxypropyl
moieti
increas
cellular
permeabl
well
antivir
activ
prodrug
probabl
due
greater
avail
cellular
phosphoryl
thu
strong
antivir
activ
hexadecyloxypropyl
ester
hpmpg
dna
viru
strain
expect
also
drug
previous
found
weakli
activ
peeg
may
show
pronounc
activ
convers
hexadecyloxypropyl
ester
addit
structureeact
relationship
among
variou
prodrug
type
diester
monoest
cyclic
monoest
report
alkyl
phosphon
function
hexadecyloxypropyl
moieti
consid
two
approach
use
peeg
model
compound
first
broadli
use
methodolog
involv
situ
prepar
bi
chlorid
follow
subsequ
reaction
hexadecyloxypropyl
alcohol
presenc
base
latter
approach
involv
neutral
phosphon
function
tetrabutylammonium
hydroxid
follow
nucleophil
reaction
result
phosphon
salt
hexadecyloxypropyl
bromid
howev
methodolog
afford
low
yield
peeg
ester
due
low
convers
simultan
alkyl
nucleobas
order
circumv
problem
alkyl
acycl
phosphon
synthon
subsequ
coupl
appropri
nucleobas
prepar
peeg
peehx
prodrug
bi
isopropyl
phosphonoethoxyethylchlorid
transform
free
phosphon
acid
subsequ
bi
chlorid
treat
hexadecyloxypropyl
alcohol
presenc
pyridin
triethylamin
bi
hexadecyloxypropyl
ester
isol
high
yield
nucleophil
substitut
reaction
alkyl
phosphon
synthon
presenc
cs
co
base
follow
acid
catalyz
cleavag
substitu
afford
bi
hexadecyloxypropyl
ester
peeg
peehx
appropri
monoest
prepar
dissolv
diester
dmf
heat
presenc
nucleophil
agent
lin
caus
remov
one
alkyl
ester
group
scheme
similar
prepar
peeg
peehx
prodrug
prepar
hpmpg
hpmphx
prodrug
began
convers
bi
isopropyl
phosphonomethyltosyl
bi
hexadecyloxypropyl
phosphonomethyltosyl
alkyl
phosphon
synthon
coupl
preprepar
presenc
base
nah
preprepar
involv
nucleophil
open
oxiran
ring
glycidol
trityl
ether
acid
labil
protect
group
obn
otr
result
adduct
cleav
action
hcl
diester
hydrolyz
solut
naoh
give
monoest
mention
method
use
milder
condit
result
incomplet
convers
case
intramolecular
esterif
mediat
pybop
afford
cyclic
hexadecyloxypropyl
ester
mixtur
diastereom
ratio
accord
nmr
spectra
scheme
esterif
acycl
nucleosid
phosphon
hpmpc
hpmpa
variou
alkoxyalkyl
alkylglycerol
group
shown
result
remark
increas
antivir
activ
herpesvirus
poxvirus
rational
behind
studi
demonstr
whether
enhanc
lipophil
hpmpg
hpmphx
peeg
peehx
correl
increas
antivir
activ
purpos
hexadecyloxypropyl
diester
monoest
cyclic
monoest
compound
prepar
antivir
properti
evalu
vitro
antivir
activ
differ
compound
evalu
variou
dna
virus
includ
poxvirus
ie
vaccinia
viru
vacv
herpesvirus
ie
herp
simplex
viru
type
type
thymidin
kinasedefici
acyclovirresist
acv
r
varicellazost
viru
vzv
human
cytomegaloviru
hcmv
tabl
retrovirus
includ
human
immunodefici
viru
type
type
compound
also
examin
sever
rna
virus
includ
vesicular
stomat
viru
vsv
coxsacki
viru
respiratori
syncyti
viru
rsv
parainfluenza
viru
type
sindbi
viru
punta
toro
viru
none
prodrug
show
activ
rna
virus
retrovirus
test
similar
parent
compound
diester
monoest
prodrug
peehx
ie
compound
prove
inact
herpesvirus
poxvirus
although
diester
prodrug
peeg
compound
lack
also
activ
dna
virus
monoest
deriv
compound
abl
potent
inhibit
replic
vzv
hsv
hcmv
ec
valu
rang
respect
mm
mm
mm
sinc
compound
inhibit
cell
growth
cc
cytostat
concentr
valu
mm
select
indic
ratio
cc
ec
rang
depend
natur
viru
interestingli
compound
inact
felin
herpesviru
vacv
among
hpmp
prodrug
attach
highli
lipophil
hexadecyloxypropyl
moieti
hpmphx
result
increas
antivir
activ
sinc
compound
monoest
diester
cyclic
monoest
total
inact
herpesvirus
poxvirus
diester
deriv
hpmpg
compound
show
ec
valu
vzv
hcmv
hsv
felin
herpesviru
vacv
lower
parent
compound
howev
monoest
cyclic
monoest
deriv
hpmpg
prove
activ
select
diester
deriv
observ
support
previou
assumpt
phosphon
doubleest
prodrug
penetr
cell
membran
less
rapidli
monoest
counterpair
even
case
ioniz
phosphon
group
present
monoest
prodrug
thu
compound
monoest
compound
cyclic
monoest
inhibit
vzv
replic
ec
valu
rang
mm
vzv
mm
hsv
mm
hcmv
monoest
deriv
hpmpg
inact
felin
herpesviru
cyclic
monoest
deriv
abl
inhibit
viral
replic
ec
mm
howev
compound
prove
activ
compound
vacv
ec
mm
compound
compar
mm
compound
monoest
deriv
hpmpg
compound
prove
significantli
cystostat
cyclic
monoest
compound
cc
mm
mm
respect
si
lower
compound
compar
compound
thu
cyclic
monoest
hpmpg
show
high
select
among
prodrug
test
si
rang
vzv
hsv
hcmv
vacv
data
show
enhanc
lipophil
hpmpg
result
increas
antivir
activ
select
vitro
herpesvirus
poxvirus
signific
gain
antivir
activ
select
compound
compar
parent
compound
explain
similar
way
anp
ie
increas
cellular
uptak
ester
deri
rapid
convers
diphosph
activ
form
also
metabol
stabil
ester
deriv
even
compound
charg
physiolog
condit
abl
penetr
cell
membran
sinc
present
signific
antivir
activ
antimicrobi
activ
bordetella
pertusi
bacillu
anthraci
prodrug
also
test
hexadecyloxypropyl
diester
monoest
cyclic
monoest
hpmpg
hpmphx
peeg
peehx
prepar
antivir
properti
evalu
vitro
none
hexadecyloxypropyl
ester
hpmphx
peehx
prove
activ
herpesvirus
poxvirus
although
hexadecyloxypropyl
diester
peeg
antivir
inact
monoest
deriv
gain
activ
herpesvirus
attach
highli
lipophil
hexadecyloxypropyl
moieti
hpmpg
result
improv
antivir
activ
herpesvirus
cyclic
monoest
deriv
hpmpg
emerg
select
antivir
compound
unless
state
otherwis
solvent
evapor
c
compound
dri
pa
purif
product
revers
phase
hplc
perform
water
delta
instrument
water
dual
l
absorb
detector
use
luna
phenomenex
prepar
column
mm
mm
flow
mlmin
elut
condit
given
text
column
chromatographi
perform
mm
silica
gel
fluka
chemic
ionexchang
resin
purchas
sigmaealdrich
czech
republ
gener
number
assign
nmr
signal
depict
fig
bi
isopropyl
phosphonoethoxyethylchlorid
g
mmol
bi
isopropyl
phosphonomethyltosyl
bromotrimethylsilan
ml
overnight
room
temperatur
mixtur
evapor
codistil
acetonitril
ml
water
ml
ethanol
ml
toluen
ml
syrupi
residu
dissolv
dichloromethan
ml
dmf
ml
oxalyl
chlorid
ml
mmol
ad
solut
gentli
reflux
h
evapor
dryness
redissolv
dichloromethan
ml
solut
cool
c
treat
slowli
pyridin
ml
mixtur
ad
cool
c
solut
hexadecyloxypropanol
g
mmol
dichloromethan
ml
triethylamin
ml
mixtur
allow
reach
c
kept
temperatur
h
reaction
mixtur
evapor
codistil
toluen
ml
residu
chromatograph
silica
gel
column
g
etoachexan
yield
g
syrup
crude
product
use
without
purif
procedur
esim
mz
prepar
similarli
accord
publish
procedur
yield
g
syrup
ident
verifi
use
authent
sampl
tlc
r
f
etoachexan
mixtur
mmol
mg
respect
bi
hexadecyloxypropyl
phosphonoethoxyethylchlorid
mg
mmol
cs
co
mg
mmol
dmf
ml
heat
c
h
reaction
aminochloropurin
h
reaction
chloropurin
mixtur
evapor
residu
chromatograph
silica
gel
column
g
meohchcl
crude
product
reflux
aqueou
acet
acid
h
concentr
chromatograph
silica
gel
column
g
meohchcl
yield
mg
yield
mg
mixtur
mmol
mg
mg
respect
lin
mmol
mg
dmf
ml
heat
c
h
evapor
syrupi
residu
chromatograph
silica
gel
column
meohchcl
combin
fraction
contain
product
evapor
dissolv
hot
water
ml
drop
aqueou
ammonia
ad
complet
dissolut
solut
neutral
aqueou
hydrochlor
acid
ph
z
crystal
product
filter
wash
water
yield
mg
mixtur
mmol
g
g
respect
glycidol
trityl
ether
g
mmol
cs
co
mg
mmol
dmf
ml
heat
c
h
solut
evapor
syrupi
residu
chromatograph
silica
gel
column
g
etoactoluen
mixtur
mmol
g
g
respect
g
mmol
anhydr
dmf
ml
treat
nah
suspens
miner
oil
mg
mmol
cool
c
mixtur
stir
room
temperatur
overnight
heat
c
h
mixtur
neutral
acet
acid
ml
mmol
partit
chloroform
ml
aqueou
satur
solut
nacl
ml
aqueou
portion
extract
chloroform
ml
combin
organ
portion
dri
mgso
evapor
syrupi
residu
chromatograph
silica
gel
column
g
gradient
etoactoluen
etoac
syrupi
trityl
deriv
dissolv
et
omeoh
ml
solut
acidifi
methanol
solut
hydrogen
chlorid
ph
stir
h
product
crystal
overnight
fridg
mother
liquor
concentr
chromatograph
silica
gel
column
methanolchloroformhexan
yield
g
solut
mmol
mg
mg
respect
dioxan
ml
aqueou
solut
naoh
ml
mmol
ad
mixtur
stir
h
solut
neutral
hydrochlor
acid
ml
mmol
mixtur
evapor
codistil
toluen
residu
chromatograph
silica
gel
column
g
methanolchloroform
